WALL, NJ--(Marketwired - Jul 11, 2017) - BIO-key International, Inc. (
To support the use of fingerprint biometric authentication, BIO-key is providing an initial 5,000 SideTouch compact fingerprint readers that have been qualified and tested by Microsoft to support the biometric sign-in capabilities of Windows Hello.
Additionally, moving forward this customer can integrate BIO-key's ID Director for Windows , a multi-factor, "Single-Sign-On" authentication software solution enabling secure authentication to a Windows domain, application or website from any device across the enterprise. ID Director for Windows plugs directly into existing Active Directory infrastructures to provide tight integration with the corporate structure for managing user and computer policies.
"Reflecting the growing base of interest in deploying fingerprint authentication within highly-regulated industries, BIO-key has received more bank inquiries about our solutions in the past 12 months than in all of the previous 12 years," stated Mike DePasquale, Chairman & CEO, BIO-key. "We believe this trend is being driven both by the escalating challenge of protecting online assets and the widespread familiarity of fingerprint authentication on smart phones and tablets. As other authentication methods continue to show signs of vulnerability, the security, accuracy, ease of use and attractive cost of fingerprint authentication is emerging as a best in class solution."
About BIO-key International, Inc. ( www.bio-key.com ) BIO-key is revolutionizing authentication with biometric solutions that enable convenient and secure access to information and secure high-stakes transactions. We offer alternatives to passwords, PINs, tokens and cards to make it easy for enterprises and consumers to secure their devices as well as information in the cloud. Our premium finger scanning devices, including SideSwipe , SideTouch , EcoID as well as SidePass, offer market-leading quality, performance and price. Now you can BIO-key your world!
BIO-key Safe Harbor Statement Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, market acceptance of biometric solutions generally and our specific offerings, our ability to expand into the Asian market, the impact on our business of the recent financial crisis in the global capital markets, and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made.
Investor & Media Contacts David Collins, William Jones, Tanya Kamatu Catalyst Global 212-924-9800 bkyi@catalyst-ir.com Twitter: BIO-keyIR https://twitter.com/BIO_KeyIR
